Jump to Main Content

Programs

Special Interest Sessions

These smaller sessions provide the opportunity for ASH’s various communities to focus on specific topics of interest, ranging from coping with physician stress and burnout, to counseling fellows on careers in hematology, to the impact of ASH’s international outreach programs.

ASH and the ASH Research Collaborative: Advancing Progress in Sickle Cell Disease Update and Reception

Monday, December 12, 2022, 6:00 p.m. - 8:00 p.m.
Marriott New Orleans Warehouse Arts District, Gravier DEF

All meeting attendees interested in sickle cell disease are invited to attend the ASH and the ASH Research Collaborative: Advancing Progress in Sickle Cell Disease Update and Reception. In 2015, ASH launched a transformative, multi-faceted, patient-centric initiative to improve outcomes for individuals living with sickle cell disease (SCD). ASH’s multifaceted SCD efforts are focused on: ? 

  • Convening multidisciplinary partners and collaborators 
  • Promoting access to high quality care 
  • Global issues 
  • Policy and advocacy 
  • Research 
  • Leveraging data

Please join us for an evening of networking and to learn about the ASH and ASH Research Collaborative SCD programs and how to be a part of this nationwide and global initiative.

back to top

ASH Choosing Wisely® Campaign: 2022 ASH Choosing Wisely Champions

Monday, December 12, 2022, 12:15 p.m. - 1:15 p.m.
Ernest N. Morial Convention Center, 243-245

In cooperation with the ABIM Foundation, ASH has introduced the Choosing Wisely Champions initiative to recognize the efforts of practitioners who are working to eliminate costly and potentially harmful overuse of tests and procedures. Each year, three individuals are invited to present on successful utilization strategies that they have developed and implemented in their practice, institution, or hospital system. This provides an opportunity for clinicians, administrators, and other medical professionals to learn about projects that might be translated to their own practices.

Chair:

Marc Stuart Zumberg, MD
University of Florida
Gainesville, Gainesville, FL

Speakers:

Carol M. Mathew, MD
University of Florida
Gainesville, FL
Reducing Unnecessary Pre-Medication Prior to Parenteral Iron Therapy

Daanish Hoda, MD
LDS Hospital
Salt Lake City, UT
Reducing Overtesting and Overdiagnosis of Clostrdioides Dificile Infection in the Setting of an HSCT Unit

Kamal K Sahu, MD, DM
University of Utah
Salk Lake City, UT
Implementation of New Electronic Medical Record Algorithm to Streamline the Appropriate Use of Rasburicase

back to top

ASH Guideline Implementation Champions

ASH Guideline Implementation to Improve Pain Management of Sickle Cell Disease

Sunday, December 11, 2022, 9:30 a.m. - 11:00 a.m.
Ernest N. Morial Convention Center, 353-355

This session, led by Dr. Rachel Rosovsky, recognizes practitioners who are working to implement evidence-based guideline recommendations at the point of care in their clinical settings.    

Jori E. May and colleagues observed frequent deviation from guideline-supported care in patients with suspicion for and with confirmed heparin-induced thrombocytopenia (HIT). In response, they developed an electronic consultation (e-consultation) system (the “HIT E-consult Service”), in which a hematologist was automatically consulted on all patients with a positive screening immunoassay for HIT.  

Jordan Schaefer and colleagues participated in a quality improvement project starting between October of 2017 and June of 2018 at six diverse clinical sites. They were able to implement an ASH guideline recommendation to reduce excess aspirin use among patients anticoagulated for VTE and sustain this effort over several years.  

Andres Vasconez Samaniego and colleagues investigated the average time to first analgesic dose delivery in the Pediatric ED to patients with Sickle Cell Disease SCD vaso-occlusive pain events and found it was higher than the national recommendation. The most current guidelines from the National Heart Lung Blood Institute and ASH were utilized to streamline pain management in the Pediatric Emergency Department.

Chair:

Rachel P. Rosovsky, MD
Massachusetts General Hospital
Boston, MA

Speakers:

Jori E. May, MD
University of Alabama at Birmingham
Birmingham, AL
ASH Guideline Implementation Project

Jordan K Schaefer, MD
University of Michigan
Ann Arbor, MI
Reducing Excess Aspirin Use Among Patients on Chronic Anticoagulation for Venous Thromboembolic Disease

W. Andres Vasconez Samaniego, MD
Johns Hopkins University/NIH National Cancer Institute
Columbia, MD
Reducing time to analgesia in the care of Sickle Cell Disease vaso-occlusive events

back to top

ASH Guidelines on AML in Older Adults: Monitoring Emerging Evidence

Monday, December 12, 2022, 4:30 p.m. - 6:00 p.m.
Ernest N. Morial Convention Center, 295-296

During this special education session, presenters will discuss the ASH guidelines on AML in Older Adults, with a focus on how emerging evidence may impact recommendations and plans for updating the guidelines as necessary. 

Chair:

Mikkael A. Sekeres, MD
University of Miami, Sylvester Comprehensive Cancer Center
Miami, FL

Speakers:

Laura C. Michaelis, MD
The Medical College of Wisconsin Inc.
Milwaukee, WI
Recommendations for less-intensive therapy in older adults and future directions

Mark R. Litzow, MD
Mayo Clinic
Rochester, MN
Recommendations for blood product transfusions and supportive care in older adults with AML

Kristen Marie O'Dwyer, MD
University of Rochester Medical Center
Rochester, NY
Recommendations for intensive therapy in older adults and future directions

back to top

ASH Guidelines on VTE: Prevention and Treatment in Patients with Cancer

Sunday, December 11, 2022, 4:30 p.m. - 6:00 p.m.
Ernest N. Morial Convention Center, 271-273

During this special education session, presenters will discuss the ASH guidelines on the prevention and treatment of venous thromboembolism in patients with cancer.

Chair:

Marc Carrier, MD, MSc, FRCPC
University of Ottawa
Ottawa, ON, Canada

Speakers:

Marc Carrier, MD, MSc, FRCPC
University of Ottawa
Ottawa, ON, Canada
Risk Assessment and Prophylaxis

Radhika Gangaraju, MD
University Of Alabama
Birmingham, AL
Treatment and Secondary Prevention

Ang Li, MD,MS
Baylor College of Medicine
Houston, TX
Implementation Strategies Regarding Venous Thromboembolism (VTE) in Patients with Cancer

Katy Toale
MD Anderson
Houston, TX
Implementation Strategies Regarding Venous Thromboembolism (VTE) in Patients with Cancer

back to top

ASH Health Equity Rounds Lunch

Sunday, December 11, 2022, 11:30 a.m. - 12:30 p.m.
Marriott New Orleans Warehouse Arts District, Cypress

Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. Lunch will be provided to in-person attendees.

Moderator:

Jacquelyn M. Powers, MD
Texas Children's Hospital
Houston, TX

Speakers:

Angela C. Weyand, MD
University of Michigan
Ann Arbor, MI
Gender Disparities in Bleeding Disorders

Paula D. James, MD,FRCPC
Queen's University
Kingston, ON, Canada
Gender Disparities in Bleeding Disorders

Jacquelyn M. Powers, MD
Baylor College of Medicine/ Texas Children's Hospital
Houston, TX
Gender Disparities in Bleeding Disorders

back to top

ASH ISTH NHF WFH Guidelines on VWD: Impact on Patients, Policy, and Allied Health Professionals

Monday, December 12, 2022, 4:30 p.m. - 6:00 p.m.
Ernest N. Morial Convention Center, 265-268

During this special education session, presenters will discuss the ASH ISTH NHF WFH guidelines on the diagnosis and management of von Willebrand disease, which were developed by leading clinical, methodological, and patient experts through a rigorous process to review evidence and write actionable recommendations. The focus of this session will be on how these guidelines impact the development of policy and how they impact the provision of care from both the patient and allied health professional perspectives. 

Chair:

Nathan T. Connell, MD,MPH
Brigham and Women's Hospital
Boston, MA

Speakers:

Jean Grow, [email protected]
Marquette University
Milwaukee, WI
Impact of the VWD Guidelines on Patients

Leonard A. Valentino, MD
National Hemophilia Foundation
New York, NY
Impact of the VWD Guidelines on the Legislative and Policy Agendas

Penni Smith, BSN
Primary Children's Hospital
Salt Lake City, UT
Impact of the VWD Guidelines on Allied Health Professionals

back to top

ASH Practice Partnership Lunch - A Return to the Classics: The Need for Classical Hematology

Sunday, December 11, 2022, 11:15 a.m. - 12:30 p.m.
Hilton New Orleans Riverside, St. James Ballroom

Classical hematologists treat conditions such as iron deficiency anemia, and they are expert at identifying and managing life-threatening conditions such as cold agglutinin disease, thrombotic thrombocytopenic purpura, acquired hemophilia, and heparin-induced thrombocytopenia. Systems-based classical hematologists work within a hospital or health care system on issues such as improving anticoagulation management and peri-operative patient blood management. classical hematology is one of the cognitive fields that does not generate revenue by giving chemotherapy or performing procedures. For this reason, classical hematologists face lower reimbursement than their counterparts practicing malignant hematology or oncology. They see fewer trainees interested in joining their ranks, likely due to the lower reimbursement and the low number of fellowship programs or placement opportunities - something ASH is currently working to address through its new Hematology-Focused Fellowship Training Program. And because there are fewer people entering this field, wait times for an appointment are often long, making it difficult for patients to access timely care.

 

In this session, panelists will explore solutions to the lack of classical hematologists, focusing on three main topics: How to do classical hematology without a hematologist, compensation models in classical hematology, and how to get young hematologists interested in classical hematology.

Chair:

Chancellor E Donald, MD
Tulane University School of Medicine
New Orleans, LA

Speakers:

Janice W. Lawson, MD
Tallahassee Memorial Hospital
Tallahassee, FL
How to Practice Classical Hematology When it's Outside your Comfort Zone

David Garcia
University of Washington
Seattle, WA
Justifying the Value of Classical Hematology

Alfred I Lee, MD,PhD
Yale University
New Haven, CT
Getting Young Hematologists Interested in Classical Hematology

back to top

ASH RC TEST

back to top

ASH-FDA Joint Symposium: Novel Approvals in Non-Malignant Hematology

Monday, December 12, 2022, 4:30 p.m. - 6:00 p.m.
Ernest N. Morial Convention Center, Great Hall AD

Speakers:

Tanya Wroblewski, MD
U.S. Food and Drug Administration
Silver Spring, MD
Introduction

Carrie Diamond, MD
U.S. Food and Drug Administration
Silver Spring, MD
A Novel Therapy for Cold Agglutinin Disease - Sutimlimab

David J. Kuter, MD, DPhil
Massachusetts General Hospital, Harvard Medical School
Boston, MA
Clinical Discussant on Current Treatment Landscape for Cold Agglutinin Disease

Tanya Wroblewski, MD
U.S. Food and Drug Administration
Silver Spring, MD
A Novel Treatment for Pyruvate Kinase Deficiency - Mitapivat

Josef T. Prchal, MD
Huntsman Cancer Institute, University of Utah
Salt Lake City, UT
Clinical Discussant for Pyruvate Kinase Deficiency

Tanya Wroblewski, MD
U.S. Food and Drug Administration
Silver Spring, MD
A New Therapy for Histiocytic Disorders - Cobimetinib

Gaurav Goyal, MD
University of Alabama at Birmingham
Birmingham, AL
Clinical Discussant on Current Treatment Landscape for Histiocytic Disorders

Carrie Diamond, MD
U.S. Food and Drug Administration
Silver Spring, MD
Panel Discussion

Gaurav Goyal, MD
University of Alabama at Birmingham
Birmingham, AL
Panel Discussion

David J. Kuter, MD, DPhil
Massachusetts General Hospital, Harvard Medical School
Boston, MA
Panel Discussion

Josef T. Prchal, MD
Huntsman Cancer Institute, University of Utah
Salt Lake City, UT
Panel Discussion

Tanya Wroblewski, MD
U.S. Food and Drug Administration
Silver Spring, MD
Panel Discussion

back to top

ASH-FDA Joint Symposium: Something Old, Something New - Recent Immunotherapy and Targeted Agent Approvals

Monday, December 12, 2022, 10:30 a.m. - 12:00 p.m.
Ernest N. Morial Convention Center, Great Hall AD

Speakers:

Bindu Kanapuru, MD
U.S. Food and Drug Administration
Vienna, VA
Introduction

Bindu Kanapuru, MD
U.S. Food and Drug Administration
Vienna, VA
Novel Bi-Specific for the Treatment of Patients with Multiple Myeloma - Teclistamab

Dan T. Vogl, MD
University of Pennsylvania
Philadelphia, PA
Clinical Discussant on the Current Treatment Landscape of BCMA CAR-Ts

Mona Elmacken, MD
U.S. Food and Drug Administration
Silver Spring, MD
Diffuse Large B-Cell Lymphoma Second Line Indication - Lisocabtagene maraleucel

Elizabeth L. Budde, MD, PhD
City of Hope National Medical Center
Duarte, CA
Clinical Discussant on Diffuse Large B-Cell Lymphoma

Ashley Woods, MD
U.S. Food and Drug Administration
Silver Spring, MD
Precision Medicine for Leukemias - Ivosedinib and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

Ehab L. Atallah, MD
Medical College of Wisconsin
Milwaukee, WI
Clinical Discussant on Newly Diagnosed Acute Myeloid Leukemia

Dianne Pulte, MD
U.S. Food and Drug Administration
Silver Spring, MD
Precision Medicine for Leukemias - Pemigatinib

Raajit K Rampal, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY
Clinical Discussant on Precision Medicine for Leukemias

Cara A. Rabik, MD, PhD
U.S. Food and Drug Administration
Silver Spring, MD
Diversity Initiatives: Enrolling a Representative Population

Ehab L. Atallah, MD
Medical College of Wisconsin
Milwaukee, WI
Panel Discussion

Andrea C. Baines, MD, PhD
U.S. Food and Drug Administration
Silver Spring, MD
Panel Discussion

Elizabeth L. Budde, MD, PhD
City of Hope National Medical Center
Duarte, CA
Panel Discussion

Angelo De Claro, MD
U.S. Food and Drug Administration
Bethesda, MD
Panel Discussion

Lori A. Ehrlich, MD,PhD
U.S. Food and Drug Administration
Silver Spring, MD
Panel Discussion

Mona Elmacken, MD
U.S. Food and Drug Administration
Silver Spring, MD
Panel Discussion

Nicole Gormley, MD
U.S. Food and Drug Administration
Bethesda, MD
Panel Discussion

Kelly J. Norsworthy, MD
U.S. Food and Drug Administration
Severna Park, MD
Panel Discussion

Dianne Pulte, MD
U.S. Food and Drug Administration
Silver Spring, MD
Panel Discussion

Cara A. Rabik, MD, PhD
U.S. Food and Drug Administration
Silver Spring, MD
Panel Discussion

Raajit K Rampal, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY
Panel Discussion

Dan T. Vogl, MD
Trustees of The University of Pennsylvania
Philadelphia, PA
Panel Discussion

Ashley Woods, MD
U.S. Food and Drug Administration
Silver Spring, MD
Panel Discussion

back to top

Blood Advances Meet the Editors

Saturday, December 10, 2022, 2:00 p.m. - 3:00 p.m.
Marriott New Orleans Warehouse Arts District, Julia

Panelists:

Margaret V. Ragni, MD, MPH
University of Pittsburgh
Pittsburgh, PA

Constantine S. Tam, MD,MBBS
Peter MacCallum Cancer Centre
Kew, VIC, Australia

back to top

Blood Advances Presents: How to Peer Review a Scientific Paper

Sunday, December 11, 2022, 11:15 a.m. - 12:15 p.m.
Ernest N. Morial Convention Center, 252-254

Panelists:

Leslie S. Kean, MD, PhD
Boston Children's Hospital, Harvard Medical School
Boston, MA

Andrew S. Weyrich, PhD
Oklahoma Medical Research Foundation
Oklahoma City, OK

back to top

Blood and Beyond

Sunday, December 11, 2022, 4:30 p.m. - 6:00 p.m.
Ernest N. Morial Convention Center, 265-268

At the ASH annual meeting each December, the science of blood, health, and disease brings together more than 30,000 hematologists from around the world for a vigorous discussion and exchange of ideas. The editors of the Blood journal take this opportunity to highlight the intersection of hematology and the humanities in bringing to light the epic story of blood. Past presenters have included Lawrence Hill, the author of Blood: The Stuff of Life, Douglas Starr the author of Blood: An Epic History of Medicine and Commerce, Tom Brokaw, the former NBC News anchor and author of A Lucky Life Interrupted. and most recently, the late Paul Farmer, Kolokotrones University Professor and the chair of the Department of Global Health and Social Medicine at Harvard Medical School whose session: Irrigating the Clinical Desert: Lessons from Haiti and Rwanda is freely available on the ASH website in tribute to his contributions to humanity and medicine.

John M. Barry has had considerable influence on both pandemic policy and flood protection. Both the Bush and Obama administrations sought his advice on influenza preparedness and response, and he was a member of the original team which developed plans for non-pharmaceutical interventions to mitigate a pandemic. Barry has served on advisory boards at M.I.T’s Center for Engineering Systems Fundamentals and the Johns Hopkins Bloomberg School of Public Health as well as on the board of the Society of American Historians. John M. Barry is Distinguished Scholar at both the Tulane University School of Public Health and Tropical Medicine and Tulane's Bywater Institute. Barry concludes in The Great Influenza that "The final lesson of 1918, a simple one yet one most difficult to execute, is that...those in authority must retain the public's trust. The way to do that is to distort nothing, to put the best face on nothing, to try to manipulate no one. Lincoln said that first, and best. A leader must make whatever horror exists concrete. Only then will people be able to break it apart." John M. Barry will address the pandemic of the past as well as the present in context of the history of American medicine.

Chair:

Nancy Berliner, MD
Editor-in-Chief, Blood, Brigham and Women's Hospital
Boston, MA

Speaker:

John M. Barry
Tulane University
New Orleans, LA
The Great Influenza: The Epic Story of the Deadliest Plague in History

back to top

Blood Presents: How to get Published in a Peer Review Journal

Saturday, December 10, 2022, 11:15 a.m. - 12:15 p.m.
Ernest N. Morial Convention Center, 252-254

Panelists:

Nancy Berliner, MD
Brigham and Women's Hospital
Boston, MA

Andrew W Roberts, MBBS,PhD
The Walter and Eliza Hall Institute of Medical Research
Parkville, VIC, Australia

back to top

Building a Nationwide Sickle Cell Disease Data Hub and Learning Community

Monday, December 12, 2022, 2:45 p.m. - 4:15 p.m.
Ernest N. Morial Convention Center, 217-219

Chair:

Alexis A. Thompson, MD, MPH
Northwestern University
Chicago, IL

Speakers:

Alexis A. Thompson, MD, MPH
Northwestern University
Chicago, IL
Session Introduction

Alexis A. Thompson, MD, MPH
Northwestern University
Chicago, IL
The Role of a Nationwide SCD Data Hub and Learning Community

Alexis A. Thompson, MD, MPH
Northwestern University
Chicago, IL
Moderated Q&A

Carole Lannon
Cincinnati Children's
Cincinnati, OH
Designing a Nationwide Learning Community

Amanda M. Brandow, DO, MS
Medical College of Wisconsin
Milwaukee, WI
Better Quality Through Better Measurement

Venee N. Tubman, MD
Texas Children's Hospital
Houston, TX
Building Your Team to Drive Improvement

Alexis A. Thompson, MD, MPH
Northwestern University
Chicago, IL
Moderated Panel Q&A

Alexis A. Thompson, MD, MPH
Northwestern University
Chicago, IL
Conclusion

back to top

Classification Clarification: Consensus and Compromise

Saturday, December 10, 2022, 2:00 p.m. - 3:30 p.m.
Ernest N. Morial Convention Center, 393-396

Confused about classifications? Looking for clarification? Join our hematopathology colleagues and hematologic malignancy experts as well as an FDA representative for a review and discussion of the new World Health Organization (WHO), International Consensus Classification (ICC), and European Leukemia Net (ELN) systems for diagnosis and management of lymphoid and myeloid disorders. There are modifications from previous, unresolved inconsistencies between existing systems, and new entities which could have profound impact on pathological reporting, clinical decision-making, clinical trial eligibility, drug labels, and disease registry reporting. The speakers will share practical paradigms and discuss steps to a future of consensus and compromise.

Co-Chairs:

Amy E. DeZern, MD
Johns Hopkins University
Baltimore, MD

Margaret Kasner, MD
Jefferson University Hospital
Philadelphia, PA

Speakers:

Rena R. Xian, MD, MS
Johns Hopkins University School of Medicine
Baltimore, MD
Changes to Myeloid Disease Classification

Lisa M. Rimsza, MD
Mayo Clinic - Scottsdale
Scottsdale, AZ
Changes to Lymphoid Disease Classification

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY
Perspective on Clinical Trial Issues

Kelly J. Norsworthy, MD
U.S. Food and Drug Administration
Severna Park, MD
FDA Perspective on Challenges Posed by Inconsistent Classifications

back to top

Disability Community Networking Breakfast

Monday, December 12, 2022, 7:30 a.m. - 9:00 a.m.
Marriott New Orleans Warehouse Arts District, Gravier EF

This breakfast is an informal community-building and networking event for members of the disability community attending the meeting. The event is hosted by the ASH Diversity, Equity, and Inclusion (DEI) Programs Subcommittee and aims to create a sense of belonging and allyship and, where possible, identify opportunities to learn more about the experiences and needs of the community to allow us to have a greater impact in our DEI efforts.

back to top

Driving Real-World Evidence for Hematologic Malignancy Research – A Joint ASH RC and EU HARMONY Session

Monday, December 12, 2022, 4:30 p.m. - 6:00 p.m.
Ernest N. Morial Convention Center, 217-219

Chair:

William A. Wood, MD,MPH
University of North Carolina at Chapel Hill
Chapel Hill, NC

Speakers:

William A. Wood, MD,MPH
University of North Carolina at Chapel Hill
Chapel Hill, NC
Session Introduction

Adam S. Sperling, MD, PhD
Dana-Farber Cancer Institute, Harvard Medical School
Boston, MA
Impact of Real-World Evidence on Research and Clinical Care: Priorities from ASH RC Data Hub

Jesús María Hernández-Rivas, MD, PhD
Hospital Salamanca
Salamanca, Salamanca, ESP
Impact of Real-World Evidence on Research and Clinical Care: Priorities from EU HARMONY Alliance (1)

Lars Bullinger, MD
Charité University Medicine Berlin
Berlin, Germany
Driving RWE for Hematologic Malignancy Research – A Joint ASH RC and EU HARMONY Session (2)

William A. Wood, MD,MPH
University of North Carolina at Chapel Hill
Chapel Hill, NC
Pandemic Preparedness: Highlighting the Role of Real-World Data Hub Programs

Samuel Rubinstein, MD
University of North Carolina-Chapel Hill
Chapel Hill, NC
Moderated Q&A (10 min)

Konstanze Döhner, MD
University Hospital Ulm
Ulm, Germany
HARMONY Alliance: Moving Toward Multicenter Real-World Data Capture in the Hematologic Malignancies in Europe

Jan Geissler
Leukemia Patient Advocates Foundation
Bern, Switzerland
HARMONY Alliance: Moving Toward Multicenter Real-World Data Capture in the Hematologic Malignancies in Europe - A Patient's Perspective.

Donna S. Neuberg, ScD
Dana-Farber Cancer Institute
Boston, MA
Building Real-World Research and Collaborative Practice Networks for Malignant Hematology

Brian Huntly, MB ChB, FRCPath, FMedSci, PhD
University of Cambridge
Cambridge, United Kingdom
Building Real-World Research and Collaborative Practice Networks for Malignant Hematology

Bindu Kanapuru, MD
U.S. Food and Drug Administration
Vienna, VA
A Regulators View: The Impact of Reliable and Relevant Real-World Data on Measuring Safety and Efficacy

Lars Bullinger, MD
Charité University Medicine Berlin
Berlin, Germany
A Call to Action and Collaboration

William A. Wood, MD,MPH
University of North Carolina at Chapel Hill
Chapel Hill, NC
Moderated Q&A

back to top

Grassroots Network Lunch

Saturday, December 10, 2022, 11:15 a.m. - 12:15 p.m.
Hilton New Orleans Riverside, St. James Ballroom

Thanks to ASH’s advocacy efforts and the ASH Grassroots Network, issues important to the future of hematology have been brought to the attention of the U.S. Congress and federal agencies. The ASH Grassroots Network Lunch provides a forum for interested members to learn how they can participate in ASH’s advocacy efforts, communicate with Congress, become effective advocates for hematology, and discuss the Society’s legislative and regulatory priorities. An overview of the Society’s 2022 advocacy accomplishments and a preview of the Society’s 2023 advocacy agenda, as well as a discussion about the potential impact of the 2022 midterm elections on policy related to hematology, will also be provided.

Chair:

Jennifer Holter Chakrabarty, MD
University of Oklahoma Health Sciences Center
Oklahoma City, OK

Speaker:

Veronica Gillispie-Bell, MD
Ochsner Health System
Kenner, LA
The Intersection of Hematology and Gynecology and How to Get Involved

back to top

Hemostasis and Thrombosis Community Networking Reception (for in-person participants)

Monday, December 12, 2022, 6:30 p.m. - 7:30 p.m.
Ernest N. Morial Convention Center, Rivergate Terrace

back to top

LGBTQIA+ Community Networking Brunch

Sunday, December 11, 2022, 11:15 a.m. - 12:15 p.m.
Marriott New Orleans Warehouse Arts District, Gravier EF

This brunch is an informal community-building and networking event for members of the LGBTQIA+ community attending the meeting. The event is hosted by the ASH Diversity, Equity, and Inclusion (DEI) Programs Subcommittee and aims to create a sense of belonging and allyship and, where possible, identify opportunities to learn more about the experiences and needs of the community to allow us to have a greater impact in our DEI efforts.

back to top

Maternal Health in Hematology - Current Resources and Future Advocacy

Monday, December 12, 2022, 10:30 a.m. - 12:00 p.m.
Ernest N. Morial Convention Center, Hall E

Maternal?morbidity and?mortality?closely intersects with hematology. In 2021, ASH indicated that?the time is right—given greater?awareness,?as well as?attention?to?health disparities and?their?intersection with?diversity, equity,?and inclusion?(DEI)—to explore opportunities?for the Society to engage?in?these?important public health?issues?more fully. The session will cover the current efforts, programs and resources (including but not limited to guidelines), as well as present upcoming plans and opportunities for engagement by hematology community.? Additionally, this session will also touch on the current political climate around the right to maternal healthcare and well-being and ways to be an effective advocate. The session will include case studies highlighting ways to bring attention to hematology and maternal health research and practice issues impacted by public policy decisions.

Part I - A Review of ASH Resources
1. Maternal Health in Hematology at ASH

Part II – Ways to be an Effective Advocate
1. Amicus Brief: a Michigan Study
1. Op-ed: a Washington Post Study
1. Grassroots Advocacy: a Tennessee Study

Moderator:

Sarah H. O'Brien, MD
Nationwide Children's Hospital
Columbus, OH

Speakers:

Jerome Dallas Winegarden III, MD
Trinity Health- Ann Arbor
Ann Arbor, MI
Amicus Brief: a Michigan Study

Mikkael A. Sekeres, MD
University of Miami, Sylvester Comprehensive Cancer Center
Miami, FL
Op-ed: a Washington Post Study

Deva Sharma, MD, MS
Vanderbilt University Medical Center
Nashville, TN
Grassroots Advocacy: a Tennessee Study

back to top

Medical Educators’ Symposium

Sunday, December 11, 2022, 7:30 a.m. - 9:30 a.m.
Marriott New Orleans Warehouse Arts District, Cypress

The Medical Educators Symposium (previously called the Hematology Course Directors Workshop) is open to all medical educators across the medical student, resident, and fellow continuum. The Medical Educators Symposium highlights cutting edge teaching techniques and theories while also showcasing participants of the ASH Medical Educators Institute. The symposium is two hours long and will begin with a general session focused on medical education principles.

Chair:

Sanjay R Mohan, MD, MSCI
Vanderbilt-Ingram Cancer Center
Nashville, TN

Speakers:

Alfred I Lee, MD,PhD
Yale University School of Medicine
New Haven, CT
Burnout and Faculty Engagement

Anish V. Sharda, MBBS
Yale University School of Medicine
New Haven, CT
Mentorship

Jennifer C. Kesselheim, MD,MEd
Dana-Farber Cancer Institute
Boston, MA
Medical Education Scholarship and Promotional Paths

Srikanth Nagalla, MBBS,MS
Miami Cancer Institute
Miami, FL
Breakout Session 1

Tamara J. Dunn, MD
Stanford University
Stanford, CA
Breakout Session 2

Rakesh P. Mehta, MD
Indiana University School of Medicine
Carmel, IN
Breakout Session 3

Leslie R Ellis, MD, MSHPEd, FACP
Atrium Health Wake Forest Baptist
Winston Salem, NC
Breakout Session 4

back to top

Meet the Blood Editors

Sunday, December 11, 2022, 11:15 a.m. - 12:00 p.m.
Marriott New Orleans Warehouse Arts District, Julia

Panelists:

Helen E. Heslop, MD, DSc (Hon)
Baylor College of Medicine
Houston, TX

Thomas L. Ortel, MD, PhD
Duke University Medical Center
Durham, NC

back to top

Meet the Blood Editors

Monday, December 12, 2022, 12:15 p.m. - 1:00 p.m.
Marriott New Orleans Warehouse Arts District, Julia

Panelists:

Selina M. Luger, MD, FRCPC
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, PA

Irene Roberts, MD
Weatherall Institute of Molecular Medicine
Oxford, ENG, United Kingdom

back to top

Promoting Minorities in Hematology Oral Presentations Jefferson Ballroom - Classical Hematology

Saturday, December 10, 2022, 6:30 p.m. - 8:00 p.m.
Hilton New Orleans Riverside, Jefferson Ballroom

ASH invites all interested meeting attendees to this event, which will showcase training and research opportunities geared toward increasing the diversity of scholars in the field of hematology. The highlight of the session will be scientific presentations from the ASH Minority Medical Student Award, the ASH Minority Resident Hematology Award, the ASH Minority Hematology Graduate Award, and the ASH Minority Hematology Fellowship Award program participants. A reception will follow the presentations.

Speakers:

Atinuke Dosunmu-Ogunbi
University of Pittsburgh
Pittsburgh, PA
The Role of Superoxide Dismutase 2 in Sickle Cell Disease

Elshafa H. Ahmed, DVM, PhD
The Ohio State University
Columbus, OH
Characterization of Epstein-Barr Virus Genome Diversity in Sub-Saharan Africa

Halimat Shadia Olaniyan, BS
University of Cincinnati College of Medicine
Covington, KY
Point of Care Evaluation of Rapid Testing Technologies in the Diagnosis of Sickle Cell Disease

Jasmin Martin, MD
American University of Antigua
Osbourn, Antigua and Barbuda
Specific Membrane Lipid Levels Correlate with the Degree of Sickling in Mouse Models

Joab Camarena, BS
Stanford University School of Medicine
Stanford, CA
Biasing Genome-Edited HSPCs Towards the Erythroid Lineage Using Truncated Epor

Miriam Osei, MD
Brigham and Women's Hospital
Boston, MA
Understanding Risk of Hematologic Malignancy in Hereditary Hemolytic Anemias and Hemoglobinopathies, a Multi-Institutional Matched Case-Control Study

Natasha Stanley
Philadelphia College of Osteopathic Medicine
Philadelphia, PA
Sars-Cov-2 Vaccination Safety in Patients with Acquired Aplastic Anemia

Tolulope Ifabiyi, MD
Case Western Reserve Hospital
Cuyahoga Falls, 
Evaluation of Biomarkers for Endothelial Activation and Hemolysis in Patients with Sickle Cell Disease

back to top

Promoting Minorities in Hematology Oral Presentations St. Charles Ballroom - Malignant Hematology

Saturday, December 10, 2022, 6:30 p.m. - 8:00 p.m.
Hilton New Orleans Riverside, St. Charles Ballroom

ASH invites all interested meeting attendees to this event, which will showcase training and research opportunities geared toward increasing the diversity of scholars in the field of hematology. The highlight of the session will be scientific presentations from the ASH Minority Medical Student Award, the ASH Minority Resident Hematology Award, the ASH Minority Hematology Graduate Award, and the ASH Minority Hematology Fellowship Award program participants. A reception will follow the presentations.

Speakers:

Amissa Sei
Morehouse School of Medicine
Atlanta, GA
Increasing Transduction Efficiency through Expansion of Stem Cells Via Nicotinamide (NAM)

Emmanuel Dwomoh
Frank H. Netter MD School of Medicine
North Haven, CT
Impact of Tacrolimus on CD19+ CAR T Cell Therapy

Florisela Herrejon Chavez, BS
Memorial Sloan Kettering Cancer Center
New York, NY
The RNA Binding Protein Syncrip Is Required for Leukemia Stem Cell Self-Renewal

Jennifer Jane Gile, MD
Mayo Clinic
Rochester, MN
Hypomagnesemia in Untreated Diffuse Large B-cell Lymphoma

Jonathan Legier, BS
Louisiana State University Health Sciences Center - New Orleans
New Orleans, LA
Phenotyping Multi-Cytokine Backpack Manufactured CAR T Cells with a 4-1BB Costimulatory Domain

Joshua J. Lara, BS
Texas Tech University Health Science Center El Paso
El Paso, TX
19S Proteasome Subunits As Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)

Lynda Villagomez, MD
The Ohio State University and Nationwide Children's Hospital
Columbus, OH
Constitutive PRMT5 Expression Drives Spontaneous Lymphoblastic Lymphoma In Vivo

Naima Hashi, MD
Mayo Clinic
Rochester, MN
Efficacy of Donor Lymphocyte Infusions in Achieving Disease Control in Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation

Ruth Wangondu, MD,PhD
St. Jude Children's Research Hospital
Memphis, TN
The Role of Ikaros (IKZF1) Alterations in B-Acute Lymphoblastic Leukemia

back to top

Promoting Minorities in Hematology Oral Presentations St. James Ballroom - Outcomes/Health Services

Saturday, December 10, 2022, 6:30 p.m. - 8:00 p.m.
Hilton New Orleans Riverside, St. James Ballroom

ASH invites all interested meeting attendees to this event, which will showcase training and research opportunities geared toward increasing the diversity of scholars in the field of hematology. The highlight of the session will be scientific presentations from the ASH Minority Medical Student Award, the ASH Minority Resident Hematology Award, the ASH Minority Hematology Graduate Award, and the ASH Minority Hematology Fellowship Award program participants. A reception will follow the presentations.

Speakers:

Alexandra Boye-Doe
University of North Carolina
Chapel Hill, NC
Remote Assessments of Transition-Readiness in Adolescents and Young Adults with Sickle Cell Disease

Allison Taylor, MD,MS
Duke University School of Medicine
Durham, 
Facilitators and Barriers to Care Encountered during Treatment in Non-Hispanic Black Patients with Newly Diagnosed Acute Myeloid Leukemia

Amanda J Llaneza, MPH
University of Oklahoma Health Sciences Center
Oklahoma City, OK
Addressing Epidemiologic Gaps in Immune Thrombocytopenia: Pregnant & Minority Patients

Carolina Velez-Mejia, MD
University of Texas Health Science Center at San Antonio
San Antonio, TX
Evaluating Survival Outcomes and Socioeconomic Disparities of Hispanics Vs Non-Hispanics for Hodgkin and Non-Hodgkin Lymphomas in United States: Understanding the Impact of Health Insurance Status

Christopher Mwaniki Wanjiku
Duke University Hospital
Durham, NC
Prevalence of Impairment in Activities of Daily Living in Adults with Sickle Cell Disease and Its Association with Disease Complications

Gabriel Roman Souza, MD
University of Texas Health San Antonio MD Anderson Cancer Center
San Antonio, TX
Clinical Characteristics and Outcomes of Veterans with Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agents: A National Retrospective Cohort Study

Jeffrey G Edwards, MD MPH
Boston Children's Hospital
Boston, MA
Socioeconomic Disparities and Risk of Stroke As Assessed By Transcranial Doppler: A Displace Study Secondary Analysis

Nicholas W Wilson
Morehouse School of Medicine
Atlanta, GA
Causes of Death in Patients with Sickle Cell Disease from a Large Population-Based Cohort

Sarah Addison, BS
Ohio State College of Medicine
Columbus, 
Disparities in the Care of Rurally Based Older Adults with Cancer

Sierra Atwater
Duke University
Durham, NC
Risk Factors for C. Diff Diagnoses in Hospitalized Pediatric Patients Undergoing Hematopoietic Cell Transplantation

Suzy Bangudi
The Ohio State University
Columbus, OH
Primary Care Provider Use and Depression Screening Among Transitioning Adolescents and Young Adults with Sickle Cell Disease 

back to top

Promoting Minorities in Hematology Reception

Saturday, December 10, 2022, 8:00 p.m. - 9:00 p.m.
Hilton New Orleans Riverside, The District Foyer

ASH invites all interested meeting attendees to attend the Promoting Minorites in Hematology reception following oral presentations by award recipients of the ASH Minority Recruitment Initiative (MRI) Awards Pathway.

back to top

Special Interest Session on Sickle Cell Disease Centers: Ensuring Appropriate Care Across the Patient Lifespan

Saturday, December 10, 2022, 4:00 p.m. - 5:30 p.m.
Ernest N. Morial Convention Center, La Nouvelle Orleans Ballroom AB

Chair:

Sophie M. Lanzkron, MD
Johns Hopkins School of Medicine
Baltimore, MD

Speakers:

Farzana Sayani, MD
Perelman School of Medicine , University of Pennsylvania
Philadelphia, PA
Challenges and Opportunities in Developing a Sickle Cell Program for Adults at Upenn

Sana Saif Ur Rehman, MD
Washington University School of Medicine
Saint Louis, MO
Consensus Recommendations on Health Maintenance for Adults with SCD

Monica L. Hulbert, MD
Washington University School of Medicine
Saint Louis, MO
Elements Needed for Comprehensive Pediatric Care

back to top

Special Session: AI and Machine Learning: A New Frontier in Hematology

Monday, December 12, 2022, 4:30 p.m. - 6:00 p.m.
Ernest N. Morial Convention Center, Great Hall BC

Artificial intelligence (AI) and related technologies are increasingly established in business, society, and beginning to be applied in healthcare. These technologies have the potential to transform research and patient care in hematology from diagnosis to prognosis and treatment selection. This session will highlight the current application of AI and machine learning (ML) in diagnostic hematology and clinical research. It will also discuss the current challenges in explaining AI and regulatory approvals of AI algorithms in healthcare. 

Dr. Nazha will discuss the basics and the differences between AI, ML, and deep learning (DL). He will review the forces that drive the excitement about AI in healthcare and why AI could be valuable in advancing research in the medical field. He will also dive deep into the mechanics of how ML and DL algorithms work and the optimal ways to use them in medicine. Finally, Dr. Nazha will discuss some of the use cases and novel advances in ML and DL in real life and medicine.

Dr. Olivier Elemento will discuss some of the recent applications of ML in diagnostic hematology. He will address the strengths and weaknesses of these methods including accuracy and biases, the extent of their current clinical use, and potential barriers to broader implementation and clinical application. Dr. Elemento will also outline future potential applications based on recent developments in the field of ML and newly available datasets.

Dr. Ilana Goldberg will discuss the current trends to incorporate AI and ML into healthcare diagnostics and treatments. She will discuss how these technology tools are being introduced in the field of hematology and possibilities for how they can continue to be developed for blood diseases.

Dr. Shannon McWeeney will review the process of transitioning ML algorithms and models from research to the clinic which include validation, bias assessment, hardening, and deployment. She will highlight current challenges in clinical data in the EHR for both model development and deployment. Dr. McWeeney will also discuss the governance, regulatory, and oversight considerations for AI/ML-based software at institutional and federal levels. Lastly, she will examine what is needed to ensure actionable decision support regarding transparency and explaining these technologies.

Chair:

Aziz Nazha, MD
Thomas Jefferson University
Philadelphia, PA

Speakers:

Aziz Nazha, MD
Thomas Jefferson University
Philadelphia, PA
AI 101: Why is AI and Machine Learning Important in Hematology?

Manja Meggendorfer, PhD
MLL Munich Leukemia Laboratory
Munich, Bavaria, Germany
The Application of Machine Learning in Diagnostic Hematology

Ilana Goldberg, PhD
National Heart, Lung, and Blood Institute
Bethesda, MD
AI in the Clinic: The Current Translation of Machine Learning Algorithms into Clinical Decision Tools

Shannon K. McWeeney, PhD
Oregon Health and Science University
Portland, OR
AI Challenges in Regulatory Approvals and Explainability

back to top

Special Symposium on Quality: Quality Improvement Education and Training

Saturday, December 10, 2022, 2:00 p.m. - 3:30 p.m.
Ernest N. Morial Convention Center, 295-296

This session, led by Dr. Michael Keng, focuses on quality improvement education and training projects and their development by physician champions and their teams.  

Chair:

Michael Keng, MD
UVA Health
Charlottesville, VA

Speakers:

Jose Azar, MD
Indiana University Simon Cancer Center
Indianapolis, IN
Realizing the Hippocratic Oath with Quality Improvement

Ashley E. Rosko, MD
The Ohio State University
Columbus, OH
Quality Improvement Project, Implementing Age-Friendly practices in Older Adults with Hematologic Malignancies

Rachael F. Grace, MD
Children's Hospital Boston
Boston, MA
Quality Improvement Project, Immune Thrombocytopenia (ITP)

back to top

Systems-Based Hematology Education and Networking Session

Sunday, December 11, 2022, 4:30 p.m. - 6:30 p.m.
Ernest N. Morial Convention Center, 252-254

This session offers an opportunity for attendees to learn about systems-based hematology (SBH) and to meet other hematologists interested in this novel career-path. The first hour focuses on highlighting examples of systems-based approaches and systems-level interventions in hematologic care. The second hour transitions to networking with drinks and hors d'oeuvres.

Chair:

Marc Stuart Zumberg, MD
University of Florida
Gainesville, Gainesville, FL

Speakers:

Marc Stuart Zumberg, MD
University of Florida
Gainesville, FL
Introduction to Systems-Based Hematology

MIchael B. Streiff, MD
Johns Hopkins Medical Institutions
Baltimore, MD
A Systems-Based Approach to the Prevention and Management of Cancer-Associated Thrombosis

Annette S. Kim, MD,PhD
Brigham and Women's Hospital
Boston, MA
Avoiding Overuse of Molecular/Genetic Testing Via Systems-Level Interventions

back to top

Training Program Directors' Workshop

Friday, December 9, 2022, 9:00 a.m. - 12:00 p.m.
Marriott New Orleans Warehouse Arts District, Cypress

The Training Program Directors Workshop is held each year before the ASH annual meeting and is designed for training program directors, associate program directors, and others involved with hematology training to share lessons learned, best practices, and explore opportunities to improve their leadership skills. Through experiential learning techniques, breakout sessions, and interactive lectures, program directors can learn from peers and build their network.

Chair:

Alfred I Lee, MD,PhD
Yale University School of Medicine
New Haven, CT

Speakers:

Alan E. Mast, MD, PhD
Versiti Blood Center of Wisconsin
Milwaukee, WI
Diversity, Equity, and Inclusion

Cecelia Calhoun, MD,MBA,MPH
Yale University
New Haven, CT
Diversity, Equity, and Inclusion

Soo Park, MD
University of California San Diego
San Diego, CA
Mentorship and Career Development

Joanne Filicko-O'Hara, MD
Thomas Jefferson University
Philadelphia, PA
Mentorship and Career Development

Valentina Baez Sosa, MD
MedStar Washington Hospital
Washington, DC
How the Personal Characteristics of Grit and Resilience Relate to Physician Well-Being  

Leslie R Ellis, MD, MSHPEd, FACP
Wake Forest Baptist Health
Winston-Salem, NC
How the Personal Characteristics of Grit and Resilience Relate to Physician Well

back to top

Women in Hematology Networking Dinner

Building Your Dream Career, Come What May

Monday, December 12, 2022, 7:30 p.m. - 9:30 p.m.
Hilton New Orleans Riverside, St. Charles Ballroom

This dinner and lecture provides a space where all can gather in an informal environment, interact with peers, connect with role models and potential mentors, and become inspired and empowered to overcome the challenges women face in hematology.

Speaker:

Arghavan Salles, MD, PhD
Stanford University
Stanford, CA
Building Your Dream Career, Come What May